Table 3. Common Pediatric Acute Myeloid Leukemia (AML) Chromosomal Translocations

Gene Fusion ProductChromosomal TranslocationPrevalence in Pediatric AML (%)
KMT2A (MLL) translocated 11q23.3 25.0
NUP98-NSD1 a t(5;11)(q35.3;p15.5)7.0
CBFA2T3-GLIS2 a inv(16)(p13.3;q24.3)3.0
NUP98-KDM5Aa t(11;12)(p15.5;p13.5)3.0
DEK-NUP214 t(6;9)(p22.3;q34.1)1.7
RBM15(OTT)-MKL1(MAL) t(1;22)(p13.3;q13.1)0.8
MNX1-ETV6 t(7;12)(q36.3;p13.2)0.8
KAT6A-CREBBP t(8;16)(p11.2;p13.3)0.5
RUNX1-RUNX1T1 t(8;21)(q22;q22)13–14
CBFB-MYH11 inv(16)(p13.1;q22) or t(16;16)(p13.1;q22)4–9
PML-RARA t(15;17)(q24;q21)6–11

aCryptic chromosomal translocation.

From: Childhood Cancer Genomics (PDQ®)

Cover of PDQ Cancer Information Summaries
PDQ Cancer Information Summaries [Internet].
Bethesda (MD): National Cancer Institute (US); 2002-.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.